PODD
Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript
Insulet Corporation (NASDAQ: PODD) Q1 2025 Earnings Call dated May. 08, 2025 Corporate Participants: June Lazaroff — Senior Director of…
Insulet Corporation (PODD) Q1 2025 Earnings Call
Insulet Corporation (NASDAQ: PODD) Q1 2025 Earnings Conference
Insulet Corporation (PODD) Q1 2026 Earnings Call
Insulet Corporation (NASDAQ: PODD) Q1 2026 Earnings Conference
Insulet Corporation (PODD) Q1 2026 Earnings Announcement
Insulet Corporation (NASDAQ: PODD) Q1 2026 Earnings Announcement
Insulet Corporation (PODD) Insulet Appoints Mike Panos as Chief Commercial Officer
Insulet Corporation (NASDAQ: PODD) FY 2026 Management Update
Insulet Corporation (PODD) Sec Form 8K
Insulet Corporation (NASDAQ: PODD) Sec Form 8K
Insulet Corporation (PODD) Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod 5 Pods in the U.S.
Insulet Corporation (NASDAQ: PODD) FY 2026 Other Release
Insulet Corporation (PODD) Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes
Insulet Corporation (NASDAQ: PODD) FY 2026 Other Release
Insulet Corporation (PODD) Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
Insulet Corporation (NASDAQ: PODD) FY 2026 Other Release
Insulet Corporation (PODD) Sec Form 8K
Insulet Corporation (NASDAQ: PODD) Sec Form 8K